Tivic Health Systems (Nasdaq:TIVC) announced today that it completed enrollment in a study for its vagus nerve stimulation (VNS) device.

A European regulatory committee now recommends approval of the Alzheimer's treatment lecanemab a few months after rejecting ...

As Merck prepares for its blockbuster immunotherapy Keytruda to face generic competition, it’s investing in a new cancer drug from LaNova.

In today’s fast-paced world, sexual health and performance are essential aspects of overall well-being for many men. As men ...